Thiogenesis Therapeutics Corp. (ROZ.P) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Aluula Composites, Inc.

Northfield Capital Corp.

The INX Digital Co., Inc.

Urbana Corp.

Palisades Goldcorp Ltd.

CoTec Holdings Corp.

Pinetree Capital Ltd.

Thiogenesis Therapeutics Corp.

Largo Physical Vanadium Corp.

International Clean Power Dividend Fund

DevvStream Holdings, Inc.

Why is Thiogenesis Therapeutics Corp. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Thiogenesis Therapeutics Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Thiogenesis Therapeutics Corp.

-26.32%

-0.21

67.23%

S&P/TSX 60

29.6%

2.24

12.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-242.33%

EBIT to Interest (avg)

-4.56

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-31.97

EV to EBIT

-4.52

EV to EBITDA

-4.52

EV to Capital Employed

-27.49

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at CAD -0.92 MM

PRE-TAX PROFIT(Q)

Highest at CAD -0.91 MM

NET PROFIT(Q)

Highest at CAD -0.91 MM

EPS(Q)

Highest at CAD -0.02

-9What is not working for the Company

NET PROFIT(9M)

At CAD -5.03 MM has Grown at -57.38%

OPERATING CASH FLOW(Y)

Lowest at CAD -5.91 MM

ROCE(HY)

Lowest at -724.21%

DEBT-EQUITY RATIO (HY)

Highest at 398.76 %

Here's what is working for Thiogenesis Therapeutics Corp.

Operating Profit

Highest at CAD -0.92 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CAD MM)

Pre-Tax Profit

Highest at CAD -0.91 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit

Highest at CAD -0.91 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CAD MM)

EPS

Highest at CAD -0.02

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CAD)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Thiogenesis Therapeutics Corp.

Operating Cash Flow

Lowest at CAD -5.91 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Debt-Equity Ratio

Highest at 398.76 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio